A phase I QTc study of tivozanib in patients with advanced solid tumors.

被引：0
|
作者：
Chadha, Manpreet Kaur
Infante, Jeffrey R.
Cotreau, Monette M.
Jacobson, Lindsey
Strahs, Andrew Louis
Slichenmyer, William
Vargo, Dennis
Moore, Kathleen N.
机构：
[1] Virginia G Piper Canc Ctr, Scottsdale, AZ USA
[2] TGen, Scottsdale, AZ USA
[3] Sarah Cannon Canc Ctr, Nashville, TN USA
[4] AVEO Pharmaceut, Cambridge, MA USA
[5] Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
445
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I study of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors.
    Cescon, David W.
    Hansen, Aaron Richard
    Razak, Albiruni Ryan Abdul
    Stayner, Lee-Anne
    Hilton, John Frederick
    Renouf, Daniel John
    Denny, Trisha
    Fletcher, Graham
    Mak, Tak W.
    Bray, Mark R.
    Bedard, Philippe L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors.
    Blagden, S
    Seebaran, A
    Molife, R
    Payne, M
    Reid, A
    Protheroe, A
    Kathman, S
    Williams, D
    Bowen, C
    Hodge, J
    Dar, M
    de-Bono, J
    Middleton, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9119S - 9119S
  • [43] Phase I study of ispinesib (SB-715992) in combination with capecitabine in patients with advanced solid tumors.
    Calvo, E
    Chu, Q
    Till, E
    Rowinsky, EK
    Patnaik, A
    Takimoto, C
    Kathman, SJ
    Williams, DD
    Bowen, CJ
    Hodge, JP
    Dar, MM
    Tolcher, AW
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9120S - 9120S
  • [44] A phase I study of doxorubicin in horses with advanced tumors.
    Theon, A. P.
    Magdesian, G. K.
    Pusterla, N.
    Wilson, W. D.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (03) : 667 - 667
  • [45] Phase I trial of Amplimexon™ (imexon, inj.) in patients with advanced solid tumors.
    Dragovich, T
    Mendelson, D
    Gordon, M
    Wong, L
    Dorr, R
    Chow, S
    Grenier, K
    Hersh, E
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9122S - 9122S
  • [46] Phase I trial of weekly irinotecan plus docetaxel in patients with advanced solid tumors.
    Font, A
    Sánchez, JM
    Guillot, M
    Abad, A
    Taron, M
    Margelí, M
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [47] CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors.
    Spencer, Kristen Renee
    Mehnert, Janice M.
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Levinson, Kelly
    Stein, Mark N.
    Huzzy, Lien
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    DiPaola, Robert S.
    Chen, Suzie
    Wen, Yvonne
    Goydos, James
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Phase Ib study of axitinib in combination with crizotinib in patients with advanced solid tumors.
    Shepard, Dale Randall
    Bruce, Justine Yang
    Garrido-Laguna, Ignacio
    Rosbrook, Brad
    Martini, Jean-Francols
    Plthavala, Yazdi K.
    Valota, Olga
    Michaelson, M. Dror
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] A phase I study of metformin and chemotherapy in solid tumors.
    Kritharis, Athena
    Caplain, Jennifer
    Rajagopal, Shrikar
    Grimm, Elizabeth
    Tsichlis, Philip N.
    Martell, Robert
    Saif, Waslf M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Phase I and pharmacokinetic study of farletuzumab in solid tumors.
    Sasaki, Yasutsuna
    Miwa, Keisuke
    Yamashita, Keishi
    Fujiwara, Keiichi
    Katsumata, Noriyuki
    Fujiwara, Yasuhiro
    Namiki, Masayuki
    Koyanagi, Nozomu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345